Australians living with HIV will soon have another treatment drug available to them at a more affordable price.
Biktarvy, a single daily tablet that combines three drugs, will be subsidised by the federal government from Friday, through its listing on the Pharmaceutical Benefits Scheme.
Each of the tablet’s components disrupt the replication of the Human Immunodeficiency Virus (HIV), which attacks some key immune cells. Read More
